One‐Year Results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II Trial
暂无分享,去创建一个
E. Braunwald | G. Knatterud | David O. Williams | T. Robertson | A. Raizner | J. Babb | M. Greenberg | A. Wasserman | J. Bresnahan | R. Ross
[1] W. Rogers,et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.
[2] J. Gore,et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. , 1991, Circulation.
[3] D. Faxon,et al. One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. , 1989, Circulation.
[4] Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.
[5] E. Braunwald,et al. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1988, The American journal of cardiology.
[6] Aims Trial Study Group. EFFECT OF INTRAVENOUS APSAC ON MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION: PRELIMINARY REPORT OF A PLACEBO-CONTROLLED CLINICAL TRIAL , 1988, The Lancet.
[7] S. Ellis,et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. , 1988, Journal of the American College of Cardiology.
[8] S. Ellis,et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. , 1988, Circulation.
[9] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[10] S. Forman,et al. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial. , 1987, Journal of the American College of Cardiology.
[11] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.
[12] A. Ross,et al. The influence of residual coronary stenosis on size of infarction after reperfusion in a canine preparation. , 1986, Circulation.
[13] E. Varnauskas. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. , 1985, Circulation.
[14] S. M. Collins,et al. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. , 1984, Circulation.
[15] Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. , 1984, The New England journal of medicine.
[16] W. Dixon,et al. BMDP statistical software , 1983 .
[17] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[18] W. J. Langford. Statistical Methods , 1959, Nature.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .